Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
CEO Spotlight: Gaston Salinas
Single-use Fermenters for Microbial Biopharma Development & Manufacturing
Creating Solutions for CDMOs: An EPCMV Firm’s Perspective
The Transformative Potential of Gene Therapy
Parenteral Perspectives
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Aurigene Pharmaceutical Services Opens Biologics Facility
AGC Biologics Completes Copenhagen Campus Expansion
CordenPharma, Certest Partner on Ionizable Lipids in LNP Formulation
Syngene Launches Platform for Enhanced Protein Production
Aragen Bioscience Validates Getinge’s Single-Use Production Reactor
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
Aurigene Pharmaceutical Services Opens Biologics Facility
AGC Biologics Completes Copenhagen Campus Expansion
Aragen Bioscience Validates Getinge’s Single-Use Production Reactor
Ecolab, Repligen Launch DurA Cycle Affinity Resin for Large-Scale Biologic Mfg.
Vetter to Expand Capacity in the U.S. and Germany
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Thermo Fisher Opens New GMP Ultra-cold Facility in the EU
The Future of the Pharmaceutical Contract Packaging Industry
PDUFA to Patients in 7 Days with Integrated Packaging Solutions
Pharma Matters Q&A: PCI Pharma Services
Pharma Matters Q&A: Marken
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Aurigene Pharmaceutical Services Opens Biologics Facility
AGC Biologics Completes Copenhagen Campus Expansion
CordenPharma, Certest Partner on Ionizable Lipids in LNP Formulation
Syngene Launches Platform for Enhanced Protein Production
Ecolab, Repligen Launch DurA Cycle Affinity Resin for Large-Scale Biologic Mfg.
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
How QMS Impacts Quality Maturity
Regulatory Affairs: Drug Shortages – No Solution in Sight!
Regulatory Affairs: A Common Warning Letter Citation Explored
The Future of Pharmacovigilance is Proactive
Parenteral Perspectives
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
Abzena
Syngene International Ltd.
CMC Pharmaceuticals
SUANFARMA CDMO
LOTTE BIOLOGICS
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
Abzena
Syngene International Ltd.
CMC Pharmaceuticals
SUANFARMA CDMO
LOTTE BIOLOGICS
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Search Results for '
monoclonal antibody
'
Search For:
Refine by Dates:
From:
To:
Past 7 Days
|
Past 30 Days
Refine By Content:
All
Advanced Degrees
Ask The Board
Ask The Experts
Back Page
Bio News & Views
Blog
Breaking News
Business Corner
Buyers Guide Companies
Case Studies
Classifieds
Columns
Company Blog
Conference Sessions
Content Microsite
Ebook
Editorial
Executive Perspective
Expert's Opinion
FDA Watch
Features
Financial Analysis
Getting Results
Glossary
I Mak
India Report
Industry Events
Infographics
Jobs
Literature / Brochures
Live From Shows
Lowe Down
Managing Your Career
News Releases
Online Exclusives
Outsourcing Survey
Pharma Beat
Podcasts
Posters
Preclinical Outsourcing
Product Releases
Salary Survey
Services
Slideshows
Sponsored Content
Top 25 Pharma & BioPharma
Top Companies Report
Trials & Filings
Videos
Webinars
White Papers / Tech Papers
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Drug Development
|
Industry News
KBI Biopharma Launches SUREmAb Monoclonal Antibody Offering
Designed to streamline processes and provide greater efficiencies in monoclonal antibody development and manufacturing.
09.12.23
Biologics, Proteins, Vaccines
Monoclonal Antibody Manufacturing Trends
Scaling upstream monoclonal antibody processes directly from 3L to 2000L.
Steven Strubbe, Technical Leader, End-to-End Solutions, part of the BioReliance portfolio, MilliporeSigma
02.01.22
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
iTeos Therapeutics, GSK Enter Monoclonal Antibody Alliance
GSK now has a leading portfolio of antibodies targeting the CD226 axis, a key target for next-gen immuno-oncology therapies
06.14.21
Breaking News
|
Clinical Trials
|
Drug Development
|
Industry News
Lilly, NIAID to Study Baricitinib in COVID-19
Baricitinib's anti-inflammatory activity has been hypothesized to have a potential benefit in COVID-19
Contract Pharma Staff
04.13.20
Collaborations & Alliances
|
Drug Development
Regeneron, Zai Lab Enter Strategic REGN1979 Alliance
Regeneron will receive $30 million upfront and is eligible to receive up to $160 million in additional regulatory and sales milestones.
Contract Pharma Staff
04.08.20
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Clinical Trials
|
Collaborations & Alliances
|
Drug Development
|
Industry News
GSK, Vir Biotechnology Enter Coronavirus Collaboration
Antibody candidates for SARS-CoV-2 to be accelerated into Phase II trials in the next 3-5 months; GSK to invest $250 million in Vir
Contract Pharma Staff
04.07.20
Breaking News
|
Drug Development
|
Industry News
Izana Initiates Namilumab Study in Worsening COVID-19
Compassionate use study of monoclonal antibody therapy will be evaluated in rapidly worsening COVID-19 patients in Italy
Contract Pharma Staff
04.06.20
Biologics, Proteins, Vaccines
The Evolution of the ADC Manufacturer
How CMDOs can rise to the occasion
Lisa McDermott and Jyothi Swamy, MilliporeSigma
04.01.20
Breaking News
|
Trials & Filings
Altasciences Completes Phase I Study in COVID-19 Patients
Gimsilumab, a monoclonal antibody, is being evaluated in patients with or at risk of developing acute respiratory distress syndrome
03.27.20
Bio News
|
Biosimilars
|
Breaking News
|
Collaborations & Alliances
|
Industry News
Alvotech, DKSH Partner to Bring Biosimilar to Asia
Biosimilar of AbbVie’s Humira to be developed and supplied by Alvotech
03.26.20
Bio News
|
Breaking News
|
cGMP Manufacture
|
Process Development
Immunogenesis, ProBioGen Enter Large-Scale Mfg. Pact
To provide cell line development, process development and GMP manufacture of Immunogenesis’ lead immuno-oncology candidate
03.25.20
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Industry News
Ology Bio & DOD Ink COVID-19 Pact
CDMO to develop, manufacture monoconal antibody for treatment, prevention of infection with COVID-19 virus for Department of Defense
03.24.20
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Drug Development
|
Industry News
Samsung Biologics, APRINOIA Enter mAb Pact
Samsung will provide cell line development, process development, cGMP manufacturing to IND filing support, for Alzheimer's antibody candidate
03.17.20
Sanofi, Regeneron in COVID-19 Pact
Begin global Kevzara (sarilumab) clinical trial program in patients with severe COVID-19
03.16.20
Breaking News
|
Collaborations & Alliances
|
Drug Development
Zydus, XOMA Enter IO Agreement
To advance an IL-2-based immuno-oncology drug candidate that combines Zydus’ IL-2 with XOMA’s novel anti-IL-2 monoclonal antibody.
03.09.20
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Industry News
|
R&D
Absolute Antibody Launches FleXpress
High-throughput recombinant antibody production service enables rapid production of large numbers of recombinant antibodies at 80 ml scale
03.05.20
Biologics, Proteins, Vaccines
|
Breaking News
|
Industry News
Gilead to Acquire Forty Seven for $4.9B
Will gain lead product candidate magrolimab in clinical development for the treatment of several cancers
03.02.20
Bio News
|
cGMP Manufacture
|
Industry News
Catalent, Zumutor Biologics Ink Mfg. Agreement
Catalent to provide process optimization and drug substance manufacturing from its Madison site for Zumutor’s lead candidate, ZM008
02.11.20
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Industry News
GenScript, Selecxine Enter Biologics Partnership
Agreement features innovative antibody drug development.
01.13.20
Breaking News
|
Drug Development
|
Industry News
Lilly to Acquire Dermira
Expands Lilly's immunology pipeline with the addition of lebrikizumab, a Phase III monoclonal antibody to treat atopic dermatitis
01.10.20
Breaking News
|
Drug Discovery
|
Industry News
|
Preclinical Outsourcing
Charles River Provides Access to Cosmic Antibody Library
Expanded antibody library launched by Distributed Bio aims to expedite the drug discovery process
12.12.19
Biologics, Proteins, Vaccines
Challenges and Opportunities in Vaccines Drug Development
As the uptake in vaccines continues to fall, the general public needs to be better informed.
Adrian Wildfire, Scientific Director, SGS Life Sciences
11.20.19
Breaking News
|
Drug Development
|
Industry News
ABL Bio, GenScript Enter Bispecific Antibody Alliance
GenScript will serve as ABL Bio’s exclusive supplier of CDMO services for IND-enabling studies and clinical material manufacturing
11.19.19
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Industry News
ABL Bio, GenScript Enter Biologics Partnership
ABL appoints GenScript as the exclusive supplier of CDMO services.
11.18.19
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Collaborations & Alliances
|
Industry News
Samsung Biologics and Ichnos Sciences Ink Mfg. Deal
Samsung to manufacture drug substance for ISB 830 Phase 3 clinical trials and for potential future global commercial supply upon regulatory approval.
11.05.19
Breaking News
|
Industry News
UCB to Acquire Ra Pharmaceuticals in $2.5B Transaction
Acquisition will add zilucoplan, a Phase III candidate to potentially compete with Alexion’s Soliris
10.18.19
Information Technology
Probing the Limits of Pharma’s Future
A retrospective on the past 20 years and a prospective on where the future will take us.
Ben Locwin, Contributing Writer
10.15.19
Drug Development
|
Trials & Filings
Eisai, Biogen Discontinue Phase III Alzheimer's Trials
Data Safety Monitoring Board recommended to discontinue trials due to unfavorable risk-benefit ratio
09.13.19
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Clinical Trial Materials
|
Collaborations & Alliances
|
Industry News
ZyVersa, Selexis and KBI Enter Devt. and Mfg. Collaboration
To advance ZyVersa’s lead inflammasome inhibitor into clinic with Selexis and KBI’s integrated development platform
09.06.19
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Industry News
CMAB and Kintor Enter Mfg. Tie-up
Collaboration aims to develop and manufacture the ALK-1 monoclonal antibody
08.23.19
Promotions & Moves
Provention Bio Appoints Clinical Development SVP
Dr. Kell will lead the PRV-031 program, including the oversight of the Phase III PROTECT study and support of regulatory submissions
08.20.19
Collaborations & Alliances
|
Drug Development
Aevi Genomic Medicine, AstraZeneca Enter Into License Agreement
Plans to initiate Phase 2 trial for treatment of Adult Onset Still's Disease and other serious rare and orphan diseases
08.07.19
Bio News
|
Breaking News
|
Collaborations & Alliances
|
Industry News
|
Scale-up/Technology Transfer
Omeros, Lonza Enter Commercial Manufacturing Agreement
Builds on existing clinical supply deal for narsoplimab
07.31.19
Bio News
|
Breaking News
|
Collaborations & Alliances
|
Drug Discovery
|
Industry News
IONTAS, Teva Enter Antibody Optimization Agreement
Partnership includes options for the screening of biophysical properties suitable for developable antibodies.
07.29.19
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Facilities
|
Industry News
Pall, Servier Enter Biomanufacturing Tie-up
Pall chosen as single-source supplier for Servier’s purpose built end-to-end biomanufacturing facility in Gidy, France
07.19.19
Teva
...
07.15.19
AstraZeneca
...
07.15.19
AbbVie
...
07.15.19
Pfizer, Inc.
...
07.15.19
Drug Development
|
Trials & Filings
FDA Approves J&J's DARZALEX in Multiple Myeloma
Results showed that DARZALEX significantly reduced the risk of disease progression or death by 44 percent
06.28.19
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Industry News
Harbour BioMed, Chia Tai Tianqing Enter Biologics Partnership
Global collaboration focused on new antibody treatments in the fields of oncology and immunology
05.14.19
Biologics, Proteins, Vaccines
|
Process Validation
Process Validation in Biologics Development
Strategies for successful process validation in the wake of faster approval timelines.
Victor Vinci and Claudia Berdugo-Davis, Catalent Biologics
05.07.19
Biologics, Proteins, Vaccines
The Biopharma Future
A look at current trends driving volume reductions in biopharmaceutical manufacturing and keys for successful outsourcing partnerships.
Karl Pinto and Dave Cunningham, Goodwin Biotechnology
05.07.19
Bio News
|
Breaking News
|
Collaborations & Alliances
|
Industry News
I-Mab, WuXi Enter Long-term Mfg. Pact
I-Mab to leverage WuXi Bio's know-how for CMC development
05.02.19
Promotions & Moves
Aduro Biotech Appoints CMO
Nuyten brings expertise as a radiation oncologist specializing in cancer biology
04.22.19
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Drug Development
|
Industry News
Ology Wins Two DoD Awards
Together totals more than $135 million
04.17.19
Collaborations & Alliances
|
Drug Development
WuXi Biologics, I-Mab Biopharma Ink Long-term Strategic Pact
WuXi to provide CMC development and commercial manufacturing
04.16.19
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Drug Development
|
Industry News
Fujifilm Accelerates Cell Line Devt. Timelines
Introduces a 10-week timeline with its Apollo X Advanced Mammalian Expression System
04.11.19
Bio News
|
cGMP Manufacture
|
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
|
Industry News
|
R&D
BioAtla & BeiGene Enter Development Pact
Agreement also covers the manufacturing and commercialization of BioAtla’s investigational CAB CTLA-4 antibody (BA3071)
04.09.19
Breaking News
|
Industry News
GTx and Oncternal Enter Merger
Creates clinical-stage company developing a diverse pipeline of novel cancer therapies
03.08.19
Breaking News
Aurigene Pharmaceutical Services Opens Biologics Facility
AGC Biologics Completes Copenhagen Campus Expansion
CordenPharma, Certest Partner on Ionizable Lipids in LNP Formulation
Syngene Launches Platform for Enhanced Protein Production
Aragen Bioscience Validates Getinge’s Single-Use Production Reactor
View Breaking News >
CURRENT ISSUE
May 2024
CDMOs: The Cornerstone of Biopharmaceutical Innovation
Pharma 4.0: CDMOs Digitalize to Enhance Customer Value
CEO Spotlight: Gaston Salinas
Parenteral Perspectives
The Transformative Potential of Gene Therapy
Cell & Gene Therapy Outsourcing
Creating Solutions for CDMOs: An EPCMV Firm’s Perspective
Single-use Fermenters for Microbial Biopharma Development & Manufacturing
View More >